Urinary Tubular Biomarkers For Predicting Kidney Outcomes in Type 2 Diabetes Mellitus: A Prospective Cohort Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20230317006

Enrollment

302

Registered

2023-03-17

Start date

2014-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus patients Urine biomarker, diabetic kidney disease, urine cystatin, urine NGAL, urine angiotensinogen, urine KIM-1

Interventions

Type 2 Diabetes mellitus who aged more than 18 years old with normoalbuminuria

Screening

Patient with normoalbuminuria

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age more than 18 years Type 2 diabetes mellitus Estimated GFR with CKD-EPI equation more than 15 mL/min/1.73 m2 All patients gave their informed consent

Exclusion criteria

Exclusion criteria: AKI within 12 weeks Pregnancy Life expectancy < 1 year Unwillingness to participate in the study History of renal, solid-organ, or bone marrow transplantation

Design outcomes

Primary

Measure	Time frame
GFR decline more than 40 7 years ml/min/1.73m2	—

Secondary

Measure	Time frame
death 7 years clinical outcome	—

Countries

Thailand

Contacts

Public ContactAtit Suwannathot

Phramongkutkalo hospital

suwannathot@gmail.com0897977744

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026